Viridian Therapeutics S.à.r.l.
14 Rue Edward Steichen, 2540 Luxembourg, Luxembourg
About the sponsor
Viridian Therapeutics is at the forefront of advancing treatments in the intersecting fields of endocrinology and ophthalmology, with a particular focus on Thyroid Eye Disease (TED). This condition, which affects the eyes and surrounding tissues, is a significant area of interest for the sponsor, reflecting their commitment to addressing complex disorders that impact both hormonal and visual health.
- Thyroid Eye Disease (TED)
- Ophthalmic Disorders
- Endocrine-Related Conditions
Through their research initiatives, Viridian Therapeutics is contributing to the development of innovative therapies that aim to improve the quality of life for individuals affected by these challenging conditions. Their strategic focus on safety and efficacy underscores their dedication to clinical excellence and patient-centered care.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.